Search | Clinical Trials Finder

The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 6:15 PM EDT

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1369–1392 of 3,258 matching trials from the local directory fallback.

Filters: Not yet recruiting Clear all

Conditions: Dementia, Mild Cognitive Impairment (MCI)
Interventions: Insole and ankle device; Device
Lead sponsor: HealthPartners Institute; Other
Eligibility: 55 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Obesity (Disorder)
Interventions: Abbot Freestyle Libre CGM; Device
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 20 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Epilepsies, Partial, Epilepsy, Seizure Disorder, Partial, Seizure, Partial, Seizure, Partial Onset, Seizures, Seizures, Focal
Interventions: Zonisamide Oral Product; Drug
Lead sponsor: Azurity Pharmaceuticals; Industry
Eligibility: 1 Month to 17 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Winston-Salem, North Carolina • Memphis, Tennessee

Conditions: Artificial Intelligence (AI)
Interventions: Biometrics (or AI Biomaker); Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Endophthalmitis
Interventions: Moxifloxacin, Placebo; Drug
Lead sponsor: Jason Ahee, M.D.; Industry
Eligibility: 40 Years and older
Enrollment: 60,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: St. George, Utah

Conditions: Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Undifferentiated Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Leukemia, Burkitt Lymphoma, Chronic Myeloid Leukemia, BCR-ABL1 Positive, Lymphoblastic Lymphoma, Mast Cell Leukemia, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome
Interventions: Allogeneic CD34+-enriched and CD45RA-depleted PBSCs, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Cyclophosphamide, Fludarabine, Total-Body Irradiation; Biological · Procedure · Drug + 1 more
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: Not listed
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Caries, Enamel Lesions
Interventions: BlueCheck, Prevident 5000ppm Booster Plus Toothpaste; Device · Drug
Lead sponsor: Colgate Palmolive; Industry
Eligibility: 13 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Lithonia, Georgia

Conditions: Metabolic Health
Interventions: Active Metabolic Product 1, Placebo Metabolic Control 1; Dietary Supplement
Lead sponsor: Radicle Science; Industry
Eligibility: 21 Years to 105 Years
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Del Mar, California

Conditions: Sanfilippo Syndrome (MPS III)
Interventions: rAAV9-CMV-hNAGLUop; Biological
Lead sponsor: NeuroGT; Industry
Eligibility: 6 Months and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy), Bladder Cancer, Bladder Cancer (BC), Non-Muscle Invasive Bladder Carcinoma, Non-Muscle Invasive Bladder Neoplasms, Non-muscle Invasive Bladder Cancer, Non-muscle Invasive Bladder Cancer (NMIBC), Transurethral Resection of Bladdertumors, Transurethral Resection of the Bladder
Interventions: HISA; Device
Lead sponsor: CAMC Health System; Other
Eligibility: 18 Years to 89 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Charleston, West Virginia

Conditions: Cannabis Use
Interventions: Enhanced Usual Care, Motivational and Behavioral Economics Informed Intervention; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 70 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Chronic Pelvic Pain
Interventions: Empowered Relief (ER) Therapy; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cigarette Smoking, Veterans
Interventions: Cessation Treatment Counseling, Cessation Treatment Nicotine Replacement Therapy (NRT), Healthy Changes Counseling, Healthy Changes Nicotine Replacement Therapy (NRT); Behavioral · Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Wound Healing
Interventions: tooth extraction; Procedure
Lead sponsor: University of Nebraska; Other
Eligibility: 65 Years to 80 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Bone Grafting, Sinus Lifting
Interventions: Bone grafting on both sides; Device
Lead sponsor: Ohio State University; Other
Eligibility: Not listed
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Anxiety, Hearing Disability, Mobility Disability
Interventions: Sham Digital Program - General health education and interactive quizzes unrelated to anxiety or CBT., Toivoa-001 - A digital Cognitive Behavioral Therapy program combined with NBHWC-certified coaching.; Device
Lead sponsor: Toivoa Inc; Industry
Eligibility: 22 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 4
States / cities: Dover, Delaware • East Orange, New Jersey • Cleveland, Ohio + 1 more

Conditions: Liver Disease, Type 2 Diabetes
Interventions: Behavioral Treatment; Device
Lead sponsor: SIPPA Solutions INC; Industry
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Jamaica, New York

Conditions: Acute Ischemic Stroke, Anterior Cerebral Artery Stroke, Anterior Cerebral Artery Syndrome, Cardioembolic Stroke, Vasogenic Cerebral Edema
Interventions: Transcranial Doppler (TCD) examination; Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Crohn's Disease, Inflammatory Bowel Diseases, Ulcerative Colitis
Interventions: Digital Mind Body Intervention mobile application; Behavioral
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Hemangioma Skin
Interventions: 5% simvastatin ointment; Drug
Lead sponsor: Joyce Teng; Other
Eligibility: 3 Months to 6 Months
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Human Papillomavirus (HPV) Vaccines
Interventions: Protect Me 4 Application + External Quality Improvement Support, Protect Me 4 Application Alone; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 99 Years
Enrollment: 1,296 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Kidney Transplant
Interventions: Social work support, mHealth app plus personalized coaching; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 339 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Fallopian Tube Cancers, High Grade Serous Adenocarcinoma of Ovary, Ovarian Cancer, Primary Peritoneal Cancer
Interventions: Standard of Care (SOC), Standard of Care + atorvastatin; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Infant and Young Children, Linezolid, Linezolid Pharmacokinetics in Young Infants, Pharmacokinetic Analysis
Interventions: Linezolid (LZD); Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 0 Days to 90 Days
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Aurora, Colorado

Search by objective public record fields.

An Insole and Ankle Device for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD)

Continuous Glucose Monitoring in Metabolic Surgery

Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures

Identification of Depressive and Anxiety Symptoms Among a Sample of Emergency Department Patients Using Artificial Intelligence (AI) Technology

Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery

Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome

Enamel Lesion Detection With New DX Tool

Radicle HealthTM VIP: A Study Assessing the Impact of Health and Wellness Products on Metabolic Health and Related Health Outcomes

Single Injection of rAAV9-CMV-hNAGLUop Gene for Patients With Mucopolysaccharidosis (MPS) IIIB

Feasibility of HISA During TURBT for NMIBC

Activity-Based Intervention to Address Cannabis Use

Empowered Relief for Chronic Pelvic Pain

Evaluating an Innovative Tobacco Treatment Approach for Veterans in Substance Use Treatment

Post-Extraction Wound Healing in Elderly

Outcomes of Different Bone Graft Combinations for Maxillary Sinus Augmentation Procedure

Reduction of Anxiety Through Dual Treatment: Digital CBT & NBHWC Coaching

Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk

Transcranial Doppler Evaluation After Endovascular Thrombectomy for Acute Ischemic Stroke (PRECISE-TCD)

Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease

Topical Simvastatin for Treating Infantile Hemangioma

Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

Tailored mHealth Coaching and Social Resource Support in Kidney Transplantation

Targeting Immune Modulation in High Grade Serous Carcinoma: Combined Effects of Chemotherapy and Atorvastatin

Oral Antibiotic Pharmacokinetics in Young Infants